insights_auto
Why is UTHR down 2.24%?
Dive Deeperchevron_right
UTHR:NASDAQ
United Therapeutics Corp
$532.78
arrow_downward
-2.24%(-12.22) 1D
$532.78
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 8, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$545.00
High
$545.00
Low
$524.79
Mkt. cap
22.85B
Avg. vol.
856.19K
Volume
1.44M
P/E ratio
19.06
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
Open
$545.00
High
$545.00
Low
$524.79
Mkt. cap
22.85B
Avg. vol.
856.19K
Volume
1.44M
P/E ratio
19.06
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.49
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Simply Wall Street
·
2 hours ago
How Revenue Decline Fears At United Therapeutics Stock Have Changed Its Investment Story
www.marketscreener.com
·
6 hours ago
United Therapeutics Insider Sold Shares Worth $5,215,015, According to a Recent SEC Filing
Stock Titan
·
6 hours ago
The CEO's family trust exercises options and sells 9,500 United Therapeutics (UTHR) shares under a trading plan.
GuruFocus
·
11 hours ago
UTHR Maintained by RBC Capital -- Price Target Raised to $708
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com